Abacavir/Lamivudine tablets are a crucial antiretroviral (ARV) medication used in combination therapy to manage HIV-1 infection, slowing viral replication and preserving immune function, not curing HIV or preventing transmission, requiring regular dosing, and important for post-exposure prophylaxis if started within 72 hours. Key considerations include a mandatory genetic test for a severe allergy risk, carrying an alert card, taking it consistently with or without food (with food if stomach upset), and monitoring for side effects like rash, fever, or fatigue, with close attention to bone health and potential lactic acidosis. Uses

• HIV Treatment: For adults and children (over 25 kg) with HIV-1, always with other ARVs.

• HIV Prevention (PEP): Can prevent HIV infection after potential exposure, if started within 72 hours.